Skip to content
  • About
    • About Us
    • Our Team
    • Publications
  • Research
    • Project 3 – Pancreas ADM
    • Project 4 – Lung
    • Pilot Project 5 – Pancreas
    • Cycle 1 (2018-2023)
      • Project 1 – Prostate
      • Project 2 – Pancreas
      • Pilot Project 1 – Pancreas
      • Pilot Project 2 – Prostate
      • Pilot Project 3 – Lung
      • Pilot Project 4 – Pancreas
    • Publication Citation
  • Education
    • Postbac-CaRE2 Training Program
    • Grad+ CaRE2
  • Outreach & Engagement
    • The CaRE2 Contact Registry
    • Community Scientist Program
    • Cancer Information and Education Materials
    • We CaRE2 The Podcast
  • Resources
    • Developmental Research Projects Awards
    • Tissue Modeling & Drug Development Core
    • Bioinformatics, Statistical & Methodological Core
  • Planning & Evaluation
  • News & Events
  • Contact
  • About
    • About Us
    • Our Team
    • Publications
  • Research
    • Project 3 – Pancreas ADM
    • Project 4 – Lung
    • Pilot Project 5 – Pancreas
    • Cycle 1 (2018-2023)
      • Project 1 – Prostate
      • Project 2 – Pancreas
      • Pilot Project 1 – Pancreas
      • Pilot Project 2 – Prostate
      • Pilot Project 3 – Lung
      • Pilot Project 4 – Pancreas
    • Publication Citation
  • Education
    • Postbac-CaRE2 Training Program
    • Grad+ CaRE2
  • Outreach & Engagement
    • The CaRE2 Contact Registry
    • Community Scientist Program
    • Cancer Information and Education Materials
    • We CaRE2 The Podcast
  • Resources
    • Developmental Research Projects Awards
    • Tissue Modeling & Drug Development Core
    • Bioinformatics, Statistical & Methodological Core
  • Planning & Evaluation
  • News & Events
  • Contact

Day: February 9, 2022

CaRE2 MPI, John Carpten, selected to chair the Biden administration’s National Cancer Advisory Board

CaRE2 leader, John Carpten, was present at the White House for the announcement of the Biden administration’s renewal of the Cancer Moonshot program that aims to reduce the national death rate from cancer by 50% in the next 25 years. Moreover, Dr Carpten was appointed as the chair of the of the National Cancer Advisory […]

Subscribe to Our Newsletter

Stay up to date with the latest news and information about CaRE2

Facebook-f Twitter Instagram Linkedin
  • About
    • About Us
    • Our Team
    • Publications
  • Research
    • Project 3 – Pancreas ADM
    • Project 4 – Lung
    • Pilot Project 5 – Pancreas
    • Cycle 1 (2018-2023)
      • Project 1 – Prostate
      • Project 2 – Pancreas
      • Pilot Project 1 – Pancreas
      • Pilot Project 2 – Prostate
      • Pilot Project 3 – Lung
      • Pilot Project 4 – Pancreas
    • Publication Citation
  • Education
    • Postbac-CaRE2 Training Program
    • Grad+ CaRE2
  • Outreach & Engagement
    • The CaRE2 Contact Registry
    • Community Scientist Program
    • Cancer Information and Education Materials
    • We CaRE2 The Podcast
  • Resources
    • Developmental Research Projects Awards
    • Tissue Modeling & Drug Development Core
    • Bioinformatics, Statistical & Methodological Core
  • Planning & Evaluation
  • News & Events
  • Contact
  • About
    • About Us
    • Our Team
    • Publications
  • Research
    • Project 3 – Pancreas ADM
    • Project 4 – Lung
    • Pilot Project 5 – Pancreas
    • Cycle 1 (2018-2023)
      • Project 1 – Prostate
      • Project 2 – Pancreas
      • Pilot Project 1 – Pancreas
      • Pilot Project 2 – Prostate
      • Pilot Project 3 – Lung
      • Pilot Project 4 – Pancreas
    • Publication Citation
  • Education
    • Postbac-CaRE2 Training Program
    • Grad+ CaRE2
  • Outreach & Engagement
    • The CaRE2 Contact Registry
    • Community Scientist Program
    • Cancer Information and Education Materials
    • We CaRE2 The Podcast
  • Resources
    • Developmental Research Projects Awards
    • Tissue Modeling & Drug Development Core
    • Bioinformatics, Statistical & Methodological Core
  • Planning & Evaluation
  • News & Events
  • Contact

All Rights Reserved © 2020-2025